W43 (Rosiglitazone maleate 8 mg (base))

Pill imprint W43 has been identified as Rosiglitazone maleate 8 mg (base).

Rosiglitazone is used in the treatment of diabetes, type 2; nonalcoholic fatty liver disease and belongs to the drug class thiazolidinediones. Risk cannot be ruled out during pregnancy. Rosiglitazone 8 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).

Rosiglitazone maleate

Imprint:

W43

Strength:

8 mg (base)

Color:

Red

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Thiazolidinediones

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

West-ward Pharmaceutical Corp.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.